NEW

Stock Screener with Intrinsic Value

×

UTHR

United Therapeutics Corporation (UTHR)

Last Price$365.0(0.4%)

Market Cap$16.2B

$2,756.2M

+25.0% YoY

$1,110.9M

+23.5% YoY

($2,926.5M)

Net Debt to FCF - (3.3x)

LTM Free Cash Flow (FCF)

$898.1M

32.6% margin

UTHR Income Statement

UTHR Income Statement Overview

Crunching data... Almost there!

UTHR Income statement key metrics

Crunching data... Almost there!

UTHR Balance Sheet

UTHR Balance Sheet Overview

Crunching data... Almost there!

UTHR Balance Sheet Metrics

Crunching data... Almost there!

UTHR Cash Flow Statement

UTHR Cash Flow Statement Overview

Crunching data... Almost there!

UTHR Cash Flow Statement key metrics

Crunching data... Almost there!

UTHR Financials

Crunching data... Almost there!

FAQ

What is the United Therapeutics Corporation (UTHR) revenue?

The United Therapeutics Corporation (UTHR) revenue is $2,327.5M, reflecting a year-over-year (YoY) growth of +20.2% YoY.

What is the United Therapeutics Corporation (UTHR) Net Income?

The United Therapeutics Corporation (UTHR) Net Income is $984.8M, showcasing a YoY growth of +35.4% YoY.

What is United Therapeutics Corporation (UTHR) net debt?

The United Therapeutics Corporation (UTHR) has a net debt of ($2,294.1M), with a Net Debt-to-Free Cash Flow (FCF) ratio of (3.1x).

What is the United Therapeutics Corporation (UTHR) Free Cash Flow (FCF)?

The United Therapeutics Corporation (UTHR) Free Cash Flow (FCF) stands at $747.6M, accounting for a 32.1% margin.